You are here: Industry Insights > COVID-19 Vaccine

News List

AstraZeneca signs manufacturing pact with Chinese firm, BioKangtai for COVID-19 vaccine expresspharma
August 07, 2020
As per the deal, AstraZeneca will deliver the first 100 million doses this year and 200 million doses by the end of 2021.
Novavax’s COVID-19 vaccine produces immune response in early study pharmatimes
August 07, 2020
Novavax has reported positive results from the Phase I portion of its Phase I/II study of its COVID-19 vaccine candidate NVX-CoV2373.
J&J Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine americanpharmaceuticalreview
August 07, 2020
Johnson & Johnson announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen’s SARS-CoV-2 investigational ...
Novavax presents positive data from Phase I COVID-19 vaccine trial europeanpharmaceuticalreview
August 07, 2020
A Phase I trial conducted by Novavax to test NVX‑CoV2373, the company’s recombinant COVID-19 vaccine candidate, showed it elicited robust antibody responses.
AstraZeneca signs first deal to supply Covid-19 vaccine in China pharmaceutical-technology
August 07, 2020
AstraZeneca partnered with Shenzhen Kangtai Biological Products to manufacture its Covid-19 vaccine candidate in mainland China, marking its first deal to supply in the country.
J&J signs pact with US for 100 million doses of COVID-19 vaccine expresspharma
August 07, 2020
The US government is committing over $1 billion for this agreement.
Novavax signs deal with Serum Institute of India for COVID-19 vaccine supply expresspharma
August 07, 2020
Serum Institute of India will have exclusive rights for the vaccine in India during the term of the deal.
UK and Valneva to invest in coronavirus vaccine manufacturing pharmaceutical-technology
August 06, 2020
The UK Government and biotech company Valneva are set to make a joint investment in a manufacturing facility in Livingston, West Lothian as part of an agreement for early access to 60 million doses of the company’s Covid-19 vaccine candidate.
Intravacc, Celonic to Develop and Produce a Novel COVID-19 Vaccine americanpharmaceuticalreview
August 05, 2020
Intravacc and Celonic have signed a research agreement to further design, develop and produce a Covid-19 vaccine based on an immunogenic Spike (S) protein of SARS-CoV-2 combined with Intravacc’s prorietary Outer Membrane Vesicle (OMV) technology.
Pfizer and BioNTech to supply 120 million Covid-19 vaccine doses to Japan pharmaceutical-technology
August 04, 2020
Pfizer and BioNTech have entered an agreement with Japan’s Ministry of Health, Labour and Welfare (MHLW) to provide 120 million doses of their BNT162 Covid-19 vaccine candidate.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page